Literature DB >> 27109057

Microarray-based technologies for the discovery of selective, RNA-binding molecules.

Fardokht A Abulwerdi1, John S Schneekloth2.   

Abstract

The identification of small molecules that bind specifically to RNA is a challenge. However, the recent explosion in knowledge about the role RNA plays in a number of physiological processes apart from coding for protein sequences makes it a highly interesting target for chemical probes and therapeutics. One technology that has played an important role in the discovery of RNA-binding molecules is microarrays. Microarrays have been broadly employed to screen, profile, and quantify RNA interactions, and will likely play an important role in the discovery of new classes of ligands going forward. Here, we discuss the development of microarray technologies, including aminoglycoside, peptide, peptoid, and small molecule microarrays, and their use in studying RNA-interacting molecules.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Aminoglycosides; Microarrays; Peptides; Peptoids; RNA; Small molecules

Mesh:

Year:  2016        PMID: 27109057      PMCID: PMC6314024          DOI: 10.1016/j.ymeth.2016.04.022

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  11 in total

1.  NMR probing of invisible excited states using selectively labeled RNAs.

Authors:  Regan M LeBlanc; Andrew P Longhini; Vitali Tugarinov; T Kwaku Dayie
Journal:  J Biomol NMR       Date:  2018-06-01       Impact factor: 2.835

2.  Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.

Authors:  Fardokht A Abulwerdi; Matthew D Shortridge; Joanna Sztuba-Solinska; Robert Wilson; Stuart F J Le Grice; Gabriele Varani; John S Schneekloth
Journal:  J Med Chem       Date:  2016-12-02       Impact factor: 7.446

3.  cat-ELCCA: catalyzing drug discovery through click chemistry.

Authors:  Amanda L Garner
Journal:  Chem Commun (Camb)       Date:  2018-06-19       Impact factor: 6.222

4.  A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing.

Authors:  Matthew D Shortridge; Matthew J Walker; Tom Pavelitz; Yu Chen; Wen Yang; Gabriele Varani
Journal:  ACS Chem Biol       Date:  2017-05-02       Impact factor: 5.100

5.  Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors.

Authors:  Lauren D Hagler; Long M Luu; Marco Tonelli; JuYeon Lee; Samuel M Hayes; Sarah E Bonson; J Ignacio Vergara; Samuel E Butcher; Steven C Zimmerman
Journal:  Biochemistry       Date:  2020-09-10       Impact factor: 3.162

6.  R-BIND: An Interactive Database for Exploring and Developing RNA-Targeted Chemical Probes.

Authors:  Brittany S Morgan; Bilva G Sanaba; Anita Donlic; Diane B Karloff; Jordan E Forte; Yuqi Zhang; Amanda E Hargrove
Journal:  ACS Chem Biol       Date:  2019-10-29       Impact factor: 5.100

7.  Synthetic ligands for PreQ1 riboswitches provide structural and mechanistic insights into targeting RNA tertiary structure.

Authors:  Colleen M Connelly; Tomoyuki Numata; Robert E Boer; Michelle H Moon; Ranu S Sinniah; Joseph J Barchi; Adrian R Ferré-D'Amaré; John S Schneekloth
Journal:  Nat Commun       Date:  2019-04-02       Impact factor: 14.919

Review 8.  Target-Directed Approaches for Screening Small Molecules against RNA Targets.

Authors:  Hafeez S Haniff; Laurent Knerr; Jonathan L Chen; Matthew D Disney; Helen L Lightfoot
Journal:  SLAS Discov       Date:  2020-05-18       Impact factor: 3.341

9.  Characterization of clinically used oral antiseptics as quadruplex-binding ligands.

Authors:  David R Calabrese; Katherine Zlotkowski; Stephanie Alden; William M Hewitt; Colleen M Connelly; Robert M Wilson; Snehal Gaikwad; Lu Chen; Rajarshi Guha; Craig J Thomas; Beverly A Mock; John S Schneekloth
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

10.  Integrative analysis of promising molecular biomarkers and pathways for coronary artery disease using WGCNA and MetaDE methods.

Authors:  Shilin Yan
Journal:  Mol Med Rep       Date:  2018-07-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.